EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Kappa Free Light Chain Index Correlates With Prognostic Biomarkers in Multiple Sclerosis and Decreases Slowly Following Treatment

Frida Duell iD, Klara Asplund Högelin iD, Benjamin Vlad iD, Stephan Neidhart, Mohsen Khademi, Ilijas Jelcic, Magnus Hansson, Faiez Al Nimer

European Journal of Neurology · 2025

DOI: 10.1111/ene.70291 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Neurology, 2025. Verfasst von Frida Duell und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurobiology, Care Sciences and Society, Karolinska Institutet and Department of Clinical Chemistry, Karolinska University Hospital, St…. Hauptthemen laut MEDLINE: Multiple Sclerosis, Immunoglobulin kappa-Chains. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Stockholm läns landsting.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

To investigate the relation between intrathecal antibody production, as reflected by kappa free light chain (KFLC) metrics, and multiple sclerosis (MS) prognosis‐related markers and study its modulation following MS treatment.

Methods

This study comprised matched plasma and cerebrospinal fluid (CSF) samples from a total of 130 persons with MS (pwMS), 99 of whom were untreated at baseline. Paired samples from 73 pwMS (18 on dimethyl fumarate (DMF), 10 on fingolimod, 6 on natalizumab, 25 on rituximab (RTX) and 14 after autologous hematopoietic stem cell transplantation (HSCT)) were used to analyze treatment effects on KFLC metrics. KFLC was measured by nephelometry while clinical and paraclinical data were collected from the patient charts. HLA typing was performed with SNP genotyping.

Results

The KFLC local concentration (KFLC loc) and index was higher in HLA‐DRB1*15:01 carriers and correlated with the number of CSF mononuclear cells, IgG index, and CSF levels of CXCL13 and neurofilament light chain, the latter particularly during remission ( r = 0.27, p = 0.045). With regard to treatment effects, we found that treatment with DMF, RTX, and HSCT resulted in a decrease of CSF‐KFLC levels and/or KFLC loc and index. Interestingly, the rate of decrease in KFLC index correlated with time since first treatment ( r = −0.41, p = 0.045).

Conclusion

These findings support an involvement of intrathecal antibodies in non‐relapsing MS pathology and inform on the effect of current treatments. The slow rate of decrease in KFLC index following B cell depletion stresses the need for early treatment start.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Multiple SclerosisImmunoglobulin kappa-ChainsHumansFemaleMaleAdultBiomarkersMiddle AgedPrognosisHematopoietic Stem Cell TransplantationNeurofilament ProteinsDimethyl FumarateFingolimod HydrochlorideRituximabNatalizumabChemokine CXCL13Immunologic FactorsImmunosuppressive Agents

Stichwörter der Autor:innen

HLA‐DRB1*15:01biomarkerscerebrospinal fluiddimethyl fumaratehematopoietic stem cell transplantationkappa free light chainsmultiple sclerosisrituximab

Substanzen

BiomarkersImmunoglobulin kappa-ChainsNeurofilament ProteinsDimethyl FumarateFingolimod HydrochlorideRituximabNatalizumabChemokine CXCL13Immunologic FactorsImmunosuppressive Agents

Autor:innen und Institutionen

  • Department of Neurobiology, Care Sciences and Society, Karolinska Institutet and Department of Clinical Chemistry, Karolinska University Hospital, Stockholm, Sweden.
  • Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden.
  • Neuroimmunology and Multiple Sclerosis Research Section, Department of Neurology, University of Zurich and University Hospital Zurich, Zurich, Switzerland.
  • Department of Laboratory Medicine, Karolinska Institutet, and Department of Clinical Chemistry, Karolinska University Hospital, Stockholm, Sweden.

ORCID-Profile: Frida Duell, Klara Asplund Högelin, Benjamin Vlad

Förderung

  • Stockholm läns landsting

Zitieren

APA

Duell, F., Högelin, K. A., Vlad, B., Neidhart, S., Khademi, M., Jelcic, I., Hansson, M., & Al Nimer, F. (2025). Kappa Free Light Chain Index Correlates With Prognostic Biomarkers in Multiple Sclerosis and Decreases Slowly Following Treatment. European Journal of Neurology. https://doi.org/10.1111/ene.70291

Vancouver

Duell F, Högelin KA, Vlad B, Neidhart S, Khademi M, Jelcic I, et al. Kappa Free Light Chain Index Correlates With Prognostic Biomarkers in Multiple Sclerosis and Decreases Slowly Following Treatment. European Journal of Neurology. 2025. doi:10.1111/ene.70291

BibTeX
@article{Duell2025,
  author = {Duell, Frida and Högelin, Klara Asplund and Vlad, Benjamin and Neidhart, Stephan and Khademi, Mohsen and Jelcic, Ilijas and Hansson, Magnus and Al Nimer, Faiez},
  title = {Kappa Free Light Chain Index Correlates With Prognostic Biomarkers in Multiple Sclerosis and Decreases Slowly Following Treatment},
  journal = {European Journal of Neurology},
  year = {2025},
  doi = {10.1111/ene.70291}
}
Kostenlos starten →